Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled "Zydus and Dr. Reddy s announce licensing agreement for co-marketing of Pertuzumab biosimilar, a critical treatment for breast cancer patients in India".